Screener
Rigel Pharmaceuticals RIGL Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's gross margin?
- Rigel Pharmaceuticals (RIGL) reported gross margin of 93.4% in Q1 2026.
- How has Rigel Pharmaceuticals's gross margin changed year-over-year?
- Rigel Pharmaceuticals's gross margin increased by 4.2% year-over-year, from 89.6% to 93.4%.
- What is the long-term trend for Rigel Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's gross margin has grown at a -1.2% compound annual growth rate (CAGR), from 99.2% to 93.3%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Rigel Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude